beSpacific on Nostr: Trial results for new #lungcancer drug are ‘off the charts’, say doctors. More ...

Trial results for new #lungcancer drug are ‘off the charts’, say doctors. More than half of patients with advanced forms of disease who took lorlatinib were still alive after five years with no progression https://www.theguardian.com/society/article/2024/may/31/trial-results-for-new-lung-cancer-drug-are-off-the-charts-say-doctors #medicine #healthcare